Get an alert when GAMA HEALTHCARE CORPORATION LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2025-03-31

Confirmation statement due

2026-05-07

Overdue

Watchouts

2 items

Cash

Latest balance sheet

Net assets

£895K

-8.6% lowest in 3 filed years

Employees

205

-25.5% lowest in 3 filed years

Profit before tax

Period ending 2025-03-31

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

5-year trend · latest reflected 2025-03-31

Metric Trend 2022-04-012023-03-312023-04-012024-03-312025-03-31
Turnover
Operating profit
Profit before tax
Net profit -£33,133-£44,922-£53,953
Cash
Total assets less current liabilities £1,073,985£979,063£895,110
Net assets £1,073,985£979,063£895,110
Equity £1,107,118£1,073,985£1,073,985£979,063£895,110
Average employees 352275205
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
Barnes Roffe Audit Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors note that the group and company are trading adequately and have sufficient working capital and other finance available to continue for a period of not less than 12 months from the date of approval of these financial statements. As such the directors believe that there are no significant uncertainties in their assessment of whether the business is a going concern and therefore have prepared the accounts on a going concern basis.”

Group structure

  1. GAMA HEALTHCARE CORPORATION LIMITED · parent
    1. GAMA Healthcare Limited 100% · England · Promotion and sale of medical products
    2. GAMA Healthcare (Foshan) Limited 100% · China · Promotion and sale of medical products
    3. Carell Limited 100% · England · Dormant
    4. GAMA Corporation Pty Limited 100% · Australia · Holding company
    5. GAMA Healthcare Pty Limited 100% · Australia · Promotion and sale of medical products (subsidiary of GAMA Corporation Pty Limited)

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 0 resigned

Name Role Appointed Born Nationality
BRAVERMAN, Guy, Dr Director 2017-05-08 May 1979 British
HANOUKA, Allen, Dr Director 2017-08-01 Jan 1974 British
SCHRETTER, Al Director 2025-11-18 Jun 1966 American

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Deb Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2025-11-18 Active
Mr Guy Braverman Individual Shares 25–50%, Voting 25–50% 2022-05-05 Ceased 2025-11-18
Dr Allen Hanouka Individual Shares 25–50%, Voting 25–50% 2022-05-05 Ceased 2025-11-18
Gama Investment Group Ltd Corporate entity Shares 25–50%, Voting 25–50% 2022-01-17 Ceased 2025-11-18
Gama Investment Group Limited Corporate entity Shares 25–50%, Voting 25–50% 2022-01-17 Ceased 2022-05-05
Dr Allen Hanouka Individual Shares 25–50%, Voting 25–50% 2017-08-01 Ceased 2022-01-17
Dr Guy Braverman Individual Shares 25–50%, Voting 25–50% 2017-05-08 Ceased 2022-01-17

Filing timeline

Last 20 of 60 total filings

Date Type Category Description
2025-11-28 RESOLUTIONS resolution Resolution
2025-11-20 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2025-11-20 AP01 officers Appoint person director company with name date PDF
2025-11-19 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-11-19 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-11-19 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-11-17 SH01 capital Capital allotment shares PDF
2025-09-18 AA accounts Accounts with accounts type group PDF
2025-08-07 PSC04 persons-with-significant-control Change to a person with significant control PDF
2025-08-07 CH01 officers Change person director company with change date PDF
2025-05-01 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-12-11 AA accounts Accounts with accounts type group PDF
2024-04-30 CS01 confirmation-statement Confirmation statement with updates PDF
2024-02-12 MA incorporation Memorandum articles
2024-02-07 RESOLUTIONS resolution Resolution
2024-01-19 SH02 capital Capital alter shares subdivision
2024-01-19 MA incorporation Memorandum articles
2024-01-19 SH08 capital Capital name of class of shares
2024-01-19 RESOLUTIONS resolution Resolution
2023-12-31 AA accounts Accounts with accounts type group

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
11

last 12 months

Capital events
1

last 24 months

Officers appointed
1

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page